抗整合素αvβ6抗体作为儿童溃疡性结肠炎患者的诊断标志物 - Suppr

Suppr

超能文献

Anti-Integrin αvβ6 Antibody as a Diagnostic Marker for Pediatric Patients With Ulcerative Colitis.

作者信息

Muramoto Yuya, Nihira Hiroshi, Shiokawa Masahiro, Izawa Kazushi, Hiejima Eitaro, Seno Hiroshi

机构信息

Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Department of Pediatrics, Kyoto University, Kyoto, Japan.

出版信息

Gastroenterology. 2022 Oct;163(4):1094-1097.e14. doi: 10.1053/j.gastro.2022.06.026. Epub 2022 Jun 13.

DOI:10.1053/j.gastro.2022.06.026

PMID:35709831

Abstract

摘要

相似文献

Anti-Integrin αvβ6 Antibody as a Diagnostic Marker for Pediatric Patients With Ulcerative Colitis.

Gastroenterology. 2022 Oct;163(4):1094-1097.e14. doi: 10.1053/j.gastro.2022.06.026. Epub 2022 Jun 13.

Identification of an Anti-Integrin αvβ6 Autoantibody in Patients With Ulcerative Colitis.

Gastroenterology. 2021 Jun;160(7):2383-2394.e21. doi: 10.1053/j.gastro.2021.02.019. Epub 2021 Feb 12.

Anti-integrin αvβ6 autoantibodies are a potential biomarker for ulcerative colitis-like immune checkpoint inhibitor-induced colitis.

Br J Cancer. 2024 May;130(9):1552-1560. doi: 10.1038/s41416-024-02647-1. Epub 2024 Mar 9.

Pyostomatitis vegetans in a pediatric patient with ulcerative colitis: case report of a rare pediatric inflammatory bowel disease extraintestinal manifestation and review of the literature.

Eur J Gastroenterol Hepatol. 2020 Jul;32(7):889-892. doi: 10.1097/MEG.0000000000001723.

Predictive value of the Pediatric Ulcerative Colitis Activity Index in the surgical management of ulcerative colitis.

J Pediatr Surg. 2013 Jul;48(7):1540-5. doi: 10.1016/j.jpedsurg.2013.03.006.

Ulcerative Colitis: Update on Medical Management.

Curr Gastroenterol Rep. 2015 Nov;17(11):44. doi: 10.1007/s11894-015-0466-9.

Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis.

Gastroenterology. 2016 Feb;150(2):477-87.e9. doi: 10.1053/j.gastro.2015.10.041. Epub 2015 Oct 30.

Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis.

J Crohns Colitis. 2013 Dec;7(11):916-22. doi: 10.1016/j.crohns.2012.12.012. Epub 2013 Jan 20.

Ulcerative colitis: Paediatric ulcerative colitis--can we predict proctocolectomy?

Nat Rev Gastroenterol Hepatol. 2012 Sep;9(9):494-5. doi: 10.1038/nrgastro.2012.153. Epub 2012 Aug 7.

Expression of HLA-DR antigens on colonic epithelium in ulcerative colitis.

Gastroenterol Jpn. 1987 Oct;22(5):571-7. doi: 10.1007/BF02776716.

引用本文的文献

Antibodies against integrin αvβ6 have high diagnostic accuracy for ulcerative colitis.

Front Immunol. 2025 Aug 21;16:1641329. doi: 10.3389/fimmu.2025.1641329. eCollection 2025.

Current and Emerging Autoantibodies in Ulcerative Colitis.

Eur J Immunol. 2025 Aug;55(8):e51721. doi: 10.1002/eji.202451721.

Expert consensus on diagnostic guidelines for pediatric inflammatory bowel disease in Japan.

J Gastroenterol. 2025 Jul 2. doi: 10.1007/s00535-025-02271-7.

Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotype.

J Crohns Colitis. 2025 May 8;19(5). doi: 10.1093/ecco-jcc/jjaf062.

Anti-Integrin αvβ6 Antibody Titer as a Predictive Biomarker of Future Treatment Escalation in Patients With Ulcerative Colitis.

Gastro Hep Adv. 2024 Oct 26;4(3):100582. doi: 10.1016/j.gastha.2024.10.022. eCollection 2025.

Anti-integrin αvβ6 Antibodies Predict Pouchitis in Patients With Ulcerative Colitis After Restorative Proctocolectomy With Ileal Pouch-Anal Anastomosis.

Inflamm Bowel Dis. 2025 Mar 3;31(3):777-785. doi: 10.1093/ibd/izae263.

Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study.

J Gastroenterol. 2025 Jan;60(1):86-95. doi: 10.1007/s00535-024-02176-x. Epub 2024 Nov 28.

Anti-integrin αvβ6 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study.

J Gastroenterol. 2025 Jan;60(1):118-126. doi: 10.1007/s00535-024-02169-w. Epub 2024 Nov 16.

Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis.

Gastroenterology. 2023 Apr;164(4):619-629. doi: 10.1053/j.gastro.2022.12.042. Epub 2023 Jan 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Anti-Integrin αvβ6 Antibody as a Diagnostic Marker for Pediatric Patients With Ulcerative Colitis.

作者信息

Muramoto Yuya, Nihira Hiroshi, Shiokawa Masahiro, Izawa Kazushi, Hiejima Eitaro, Seno Hiroshi

机构信息

Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Department of Pediatrics, Kyoto University, Kyoto, Japan.

出版信息

Gastroenterology. 2022 Oct;163(4):1094-1097.e14. doi: 10.1053/j.gastro.2022.06.026. Epub 2022 Jun 13.

DOI:10.1053/j.gastro.2022.06.026

PMID:35709831

Abstract

摘要

相似文献

Anti-Integrin αvβ6 Antibody as a Diagnostic Marker for Pediatric Patients With Ulcerative Colitis.

Gastroenterology. 2022 Oct;163(4):1094-1097.e14. doi: 10.1053/j.gastro.2022.06.026. Epub 2022 Jun 13.

Identification of an Anti-Integrin αvβ6 Autoantibody in Patients With Ulcerative Colitis.

Gastroenterology. 2021 Jun;160(7):2383-2394.e21. doi: 10.1053/j.gastro.2021.02.019. Epub 2021 Feb 12.

Anti-integrin αvβ6 autoantibodies are a potential biomarker for ulcerative colitis-like immune checkpoint inhibitor-induced colitis.

Br J Cancer. 2024 May;130(9):1552-1560. doi: 10.1038/s41416-024-02647-1. Epub 2024 Mar 9.

Pyostomatitis vegetans in a pediatric patient with ulcerative colitis: case report of a rare pediatric inflammatory bowel disease extraintestinal manifestation and review of the literature.

Eur J Gastroenterol Hepatol. 2020 Jul;32(7):889-892. doi: 10.1097/MEG.0000000000001723.

Predictive value of the Pediatric Ulcerative Colitis Activity Index in the surgical management of ulcerative colitis.

J Pediatr Surg. 2013 Jul;48(7):1540-5. doi: 10.1016/j.jpedsurg.2013.03.006.

Ulcerative Colitis: Update on Medical Management.

Curr Gastroenterol Rep. 2015 Nov;17(11):44. doi: 10.1007/s11894-015-0466-9.

Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis.

Gastroenterology. 2016 Feb;150(2):477-87.e9. doi: 10.1053/j.gastro.2015.10.041. Epub 2015 Oct 30.

Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis.

J Crohns Colitis. 2013 Dec;7(11):916-22. doi: 10.1016/j.crohns.2012.12.012. Epub 2013 Jan 20.

Ulcerative colitis: Paediatric ulcerative colitis--can we predict proctocolectomy?

Nat Rev Gastroenterol Hepatol. 2012 Sep;9(9):494-5. doi: 10.1038/nrgastro.2012.153. Epub 2012 Aug 7.

Expression of HLA-DR antigens on colonic epithelium in ulcerative colitis.

Gastroenterol Jpn. 1987 Oct;22(5):571-7. doi: 10.1007/BF02776716.

引用本文的文献

Antibodies against integrin αvβ6 have high diagnostic accuracy for ulcerative colitis.

Front Immunol. 2025 Aug 21;16:1641329. doi: 10.3389/fimmu.2025.1641329. eCollection 2025.

Current and Emerging Autoantibodies in Ulcerative Colitis.

Eur J Immunol. 2025 Aug;55(8):e51721. doi: 10.1002/eji.202451721.

Expert consensus on diagnostic guidelines for pediatric inflammatory bowel disease in Japan.

J Gastroenterol. 2025 Jul 2. doi: 10.1007/s00535-025-02271-7.

Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotype.

J Crohns Colitis. 2025 May 8;19(5). doi: 10.1093/ecco-jcc/jjaf062.

Anti-Integrin αvβ6 Antibody Titer as a Predictive Biomarker of Future Treatment Escalation in Patients With Ulcerative Colitis.

Gastro Hep Adv. 2024 Oct 26;4(3):100582. doi: 10.1016/j.gastha.2024.10.022. eCollection 2025.

Anti-integrin αvβ6 Antibodies Predict Pouchitis in Patients With Ulcerative Colitis After Restorative Proctocolectomy With Ileal Pouch-Anal Anastomosis.

Inflamm Bowel Dis. 2025 Mar 3;31(3):777-785. doi: 10.1093/ibd/izae263.

Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study.

J Gastroenterol. 2025 Jan;60(1):86-95. doi: 10.1007/s00535-024-02176-x. Epub 2024 Nov 28.

Anti-integrin αvβ6 autoantibody in primary sclerosing cholangitis: a Japanese nationwide study.

J Gastroenterol. 2025 Jan;60(1):118-126. doi: 10.1007/s00535-024-02169-w. Epub 2024 Nov 16.

Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis.

Gastroenterology. 2023 Apr;164(4):619-629. doi: 10.1053/j.gastro.2022.12.042. Epub 2023 Jan 10.